Keywords: Cubist Pharma, Strategic goals, Financial forecsts, Cubicin, Entereg, Fundacion MEDINA, Collaboration, Antibiotics discovery

Cubist unveils five-year strategic goals; enters antibiotics collaboration

Article | 12 June 2012

USA-based Cubist Pharmaceuticals (Nasdaq: CBST) has announced its five-year strategic aspirations – Building Blocks of Growth – at its Investor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Fundacion MEDINA

Cubist Pharmaceuticals

Go to company listing

Related Drugs

Cubicin

Entereg

Go to drug listing